Friday 6 November 2026 Export BAX’s income statement to Excel — free account

Baxter International Inc.

BAX Healthcare Medical Instruments & Supplies

Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024.

Revenue: +4.97%
EPS: +731.9%
Free cash flow: +255.6%
Total debt: −9.48%

Quarter to September 2026, against a year earlier

25.73 0.08 +0.31%

Follow BAX

Alert me

Market cap: $13.3B
P/E: 0.0×
Fwd P/E: 21.3×
Dividend yield: 0.16%
F-score: 4/9
Altman Z: 2.12
Beneish M: −2.67
Dividend safety: 0/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Baxter International Inc. 10-Q filed Aug 5, 2025

Fiscal Q2 2025 · Period ended Jun 30, 2025 · Filed Aug 5, 2025 · accepted 4:48 PM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Part II, Item 1A, Risk Factors, against the 10-Q filed May 6, 2025: no changes